Diversified Healthcare Trust

Diversified Healthcare Trust reported Q2/2026 EPS of -$0.16 (expectation -$0.14) and revenue of $365.39 million, slightly below estimates. Operational metrics improved significantly: consolidated same-property NOI rose 20.2%, SHOP-segment NOI increased 37.2% with occupancy at 83.1% and rising rents. Net leverage fell to 7.1x annualized adjusted EBITDARE, and the company confirmed the June-updated full-year 2026 outlook. Management attributes the miss partly to timing effects and emphasizes continued operational momentum and balance-sheet improvement. » More on de.investing.com

At Diversified Healthcare Trust’s annual meeting, shareholders elected seven board members to one-year terms through 2027; the vote results and broker non-votes were disclosed in the SEC filing. A non-binding Swiss vote on executive compensation received majority support. Deloitte & Touche LLP was confirmed as the independent auditor for 2026; the company also reported Q1-2026 results that missed analyst expectations for EPS and revenue, though the stock rose in after-hours trading. » More on de.investing.com

Bull case argues Diversified Healthcare Trust is undervalued and could reach $8–12 within 18 months as the September 2025 dissolution of AlerisLife and handover of senior housing operating portfolio (SHOP) to third‑party operators boosts occupancy, margins and SHOP NOI by $50–80m. SHOP asset valuations appear materially below private‑market comps, and operator transitions to firms like Discovery Senior Living and Sinceri should improve efficiency and unlock operating leverage. Additional upside drivers include asset monetization, accelerated deleveraging and retail re‑rating, while governance ties to The RMR Group remain an overhang. » More on finance.yahoo.com